Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing beta IVS-II-654 transgene mouse model carrying human beta globin gene

A technology of transgenic mice and β-globin, applied in botany equipment and methods, biochemical equipment and methods, genetic engineering, etc.

Active Publication Date: 2012-01-11
SHANGHAI CHILDRENS HOSPITAL
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This shows the prospect for the application of lentiviral vectors in clinical trials, but the stability and safety of gene therapy mediated by lentiviral vectors still need further observation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing beta IVS-II-654 transgene mouse model carrying human beta globin gene
  • Method for preparing beta IVS-II-654 transgene mouse model carrying human beta globin gene
  • Method for preparing beta IVS-II-654 transgene mouse model carrying human beta globin gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 , Construction of human β globin gene lentiviral expression vector and viral packaging

[0027] Such as figure 1 As shown, construct human β globin gene lentiviral expression vector, specifically as follows

[0028] 1.1 Cloning of human β-globin gene

[0029] According to the genome sequence of human β-globin (β-globin) published by Genebank, the primer pair HP1 and HP2 were designed, and its sequence is as follows:

[0030] Primer HP 1: 5'-AGGTTGCAGTGAGCTGAGAT-3';

[0031] Primer HP2: 5'-GCGAGCTTAGTGATACTTGT-3'.

[0032] Using normal human genomic DNA as a template, amplify the human β-globin gene fragment (including 3 exons and 2 introns), as follows:

[0033] PCR reaction system: 2.5μl 10×PCR buffer, 2μl MgCl 2 (25mM), 2μl dNTP (2.5mM), 0.6μl primer (10pmol / μl), 0.2μl Taq enzyme (5U / μl), add double distilled water to 25μl.

[0034] PCR reaction conditions: denaturation at 94°C for 5min; (94°C for 45sec, 60°C for 45sec, 72°C for 60sec) x 32 cycles; 7...

Embodiment 2

[0047] Example 2 , Preparation of transgenic mice

[0048] The LBG virus particles obtained in Example 1 were injected into wild-type mice and β 654 The perivitelline space (under the zona pellucida) of fertilized eggs obtained from mating mice, each fertilized egg was injected with 5×10 -4 μl of virus suspension, and then the fertilized eggs were transplanted into the oviducts of pseudopregnant mice, developed in utero to birth, and two different types of primary transgenic mouse models were obtained. The primary mice F0 were mated with wild-type mice to generate offspring mice F1 and F2.

Embodiment 3

[0049] Example 3 , Identification of transgenic mice

[0050] After the mice were born, the tails of the mice were clipped to extract genomic DNA, and then PCR reactions were performed to design LTR (detection of lentivirus), β-major (detection of mouse β-major gene) and β654 primers to detect the genotype of mice.

[0051] The PCR primers are as follows:

[0052] LTR-1: 5'-GACTTACAAGGCAGCTGTAG-3';

[0053] LTR-2: 5'-GTACAGTCCGGATGCAGCTC-3'.

[0054] Product length: 586bp

[0055] β-major-1: 5′-AGGCAGCTCACAAGAAGAAG-3′;

[0056] β-major-2: 5'-TGGAGACTGCTCCCTAGAAT-3'.

[0057] Product length: 421bp

[0058] β654-1: 5'-AGTGATAATTTCTGGGTTAAGGT-3';

[0059] β654-2: 5'-AGGGCCTAGCTTGGACTCAG-3'.

[0060] Product length: 179bp

[0061] PCR reaction conditions: denaturation at 94°C for 5min; (94°C for 45sec, 60°C for 45sec, 72°C for 60sec) x 32 cycles; 72°C for 10min.

[0062] The PCR product was detected by 2% agarose gel electrophoresis, the results are shown in figure 2 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing a beta<IVS-II-654> thalassemia transgenic mouse model carrying human beta-globin gene. A lentiviral vector mediated human beta-globin gene is stably integrated in the genome of the mouse model, and the genome can be expressed continuously and stably; furthermore, the genome can also be inherited to the offspring and maintain the original expression level, thus phenotypes such as hematology, pathology and the like of the beta<IVS-II-654> thalassemia transgenic mouse model carrying the human beta-globin gene are improved. The mouse model prepared by the method can be used for evaluating the effectiveness, the stability and the security of the lentiviral vector mediated human beta-globin gene in the treatment of beta<IVS-II-654> thalassemia.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a β-globin gene carrying human β-globin IVS-II-654 Preparation method of transgenic mouse model. Background technique [0002] Beta thalassemia is one of the most common monogenic disorders, with approximately 80 million carriers worldwide. β-thalassemia is mainly a chronic anemia caused by a point mutation or deletion of the β-globin gene, resulting in reduced or complete lack of β-globin chain synthesis. It is widely prevalent in the Mediterranean region, the Middle East, Southeast Asia and Africa, and the southern provinces of my country are also high-incidence areas . Severe beta thalassemia manifests as impaired erythropoiesis and severe anemia requiring lifelong blood transfusions to sustain life. However, due to the deposition of iron ions, the patient eventually died of organ failure. [0003] beta IVS-II-654 Thalassemia is a mutation type of β-thalassemia unique to Chine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/09C12N15/12C12N15/86A01K67/027
Inventor 曾溢滔李伟曾凡一黄淑帧
Owner SHANGHAI CHILDRENS HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com